Member Info for LikeOriginal

The abstract is marked as "Publication Only" which means there will be no poster or oral presentation (according to the ASCO guidelines - please correct if I am wrong). This makes sense given the trial is due to officially complete its primary endpoint next month so would expect the final data at that point, not in an earlier partial release poster presentation.

I believe the ASCO abstract is "Publication only", meaning no poster or oral presentation, just publication in the journal. Can anyone else confirm?

Https://www.asco.org/abstracts-presentations/264652

Https://www.investormeetcompany.com/updates/aacr-2026-ava6103-fap-exd-preclinical-and-clinical-trial-in-progress-highlights-rink-c-et-al/show

Https://www.investormeetcompany.com/updates/avacta-academy-series/show

New drug development podcast series on investormeetcompany.

https://www.investormeetcompany.com/updates/avacta-academy-series-1/show

Important to contextualise this in the context of advanced and metastatic SGC where responses to treatment are rare, and responses to non-biomark targeted therapies are even rarer.

Brilliant episode!! Extremely clear presentation. AVA6103 programme looking fantastic. Well done to the Avacta team!

Further down the page it suggests late breaking abstracts, which needed to be submitted last week will be accepted or rejected this week.

Anyone have any thoughts on the likelihood of late breaking abstracts at ESMO? My understanding is that acceptances would be made in the next couple of days based on the ESMO guidelines.

https://www.esmo.org/meeting-calendar/esmo-congress-2025/abstracts

Might be coincidence but the HE1 website is down and 'undergoing maintenance' so possibly some updates there soon.

With regards to a placing, I think he could - I'm sure there would be enough uptake. But it does seem that he is much more likely to continue pursuing financing with the current lead bondholder as he has suggested in the recent releases. My guess would be that the reason financing with the current lead bondholder is taking a little longer than previous cash releases might relate to the current SP (going back to previous comments on the lack of importance of SP to the management team). If new bonds are to be issued with conversion potential at the current SP there is a real chance it could push the bondholders over the 50% ownership threshold if I'm not mistaken (assuming the kind of cash needed for the gas pressure reworks). Art will surely want to avoid this and so we might see a different form of financing from the bondholders? Any thoughts on this?

Haha oh dear, sorry for boring everyone, but I think the post has been misunderstood. I'm more than happy waiting to see what happens with the delisting, however long the wait might be. Although myself, and I think others too, are a little concerned that HSBC (as a broker) intend to transfer our shares over to the Canadian market (which typically trades at a lower price than the UK market with much lower volume), and we're simply interested in understanding the situation and whether this is even possible while delisted? It was no criticism of the share or anything like that - I'm very positive on COPLs future.

Thanks for the replies.

Likewise, I think it's especially frustrating that they seem to know very little about the current situation given they're 5% holders.

With regards to transferring the shares, @Aargee, that was my understanding too - hopefully we'll hear something more concrete soon. I'll definitely get in touch with them again in the next day or so to follow-up and I'll share any worthwhile information.

Just looking for some opinions on a letter I received this morning from HSBC:

"You currently hold XXX shares of Canadian Overseas Petroleum Limited (the "Company") in your HSBC InvestDirect investment account. We're letting you know that:

Further to our correspondence dated 13 April 2021 regarding the suspension of the Company's common shares.

The Company has issued no further updates regarding the timing for the cancellation and re-admission of its common shares on the London Stock Exchange (the "LSE"), prior to delisting.

As these shares are currently trading in the Candian market, we have arranged to move your holdings there, to enable you to continue to hold and trade them."

I've spoken to HSBC this morning as I definitely do not want the shares transferred over to the Canadian market. They told me that this has not happened yet but that they are not sure what is going on (now escalated to senior management and awaiting reply).

To my knowledge, a transfer wouldn't be possible for two reasons:
- The shares are currently delisted
- HSBC dont trade in the Canadian market (I don't think - please correct me)

Has anyone else with a HSBC holding had any other information?

Thanks All

Haven't received an updated letter yet. I rang HSBC last week (must have been Monday or Tuesday) and they told me a new letter was being sent in the next few days - they couldn't tell me more than that which was a little frustrating. Would also be interested to know if anyone else has had anything through?

My understanding of a CFD is that it's essentially a pre-agreed buy/sell trade at a certain point in time? So they gamble on the price going up (or down) over a certain period of time and then have to sell (or buy) at the agreed time. Am I understanding it correctly?

In this case, they lost the gamble on the SP increasing as the first holdings RNS was announced for the 19th Jan, well after the placing, meaning they would have bought in likely around the 0.25/0.26 price region, and then sold today, probably for a little less?

Agreed, but I think it was a given that the company was always going to need more money raised to fund some of the additional work. If this money is spent growing the asset base or paying for drilling/licenses etc. then it should be growing the value of the company which I don't mind so much. But yeah you're right, the longer things get delayed, the more gets spent on salaries while waiting for material income, which isn't ideal. Would be really nice to see some more information on finances and preojections, particularly thinking about El Romeral, which given the transfer date will need to be accounted for in the 2019 financial results (and hasnt been so far - there should be income from this)

I am really hoping the fundamentals of the company will eventually come good. At the end of the day the company has a wide array of assets (a lot of which are derisked) and an extremely low market cap. I think the timelines are the main stalling point (and yes, some slicker and more frequent PR would be very welcome too - I definitely don't see this as a lifestyle share like some have claimed). Definitely frustrating at the moment but a reminder that beyond the inevitable (COVID-related) delays there hasn't really been any bad news (coming from the perspective that the share consolidation does not change any of the companies fundamentals).

The AGM items seem heavily geared towards a major overhaul and re-branding of the company (not just the name). Does anyone have any thoughts on the potential to move to a different exchange with the higher share price after the consolidation?